|
Mayo Clinic will be the lead institution providing coordinated access to investigational convalescent plasma for hospitalized patients with severe or life-threatening COVID-19, or those at high risk of progression to severe or life-threatening disease. The Food and Drug Administration (FDA) announced the designation. Cured coronavirus patients are donating plasma to save more people, as results show convalescent plasma has been effective in curing patients with severe symptoms.
|
|
Science
|
Technology
|
Engineering
|
Mathematics
|
Empowerment
|